Get deeper insights around your disease of interest
IQVIA MIDAS® is widely recognized as the industry gold-standard dataset of historical drug volumes and sales. It provides an extensive view of the global market landscape and enables you to track the performance, market share and growth of 1.6 million products in 93 countries.
With the new MIDAS Disease, you’ll be able to take your analytical capabilities to another level to help accelerate your performance and outcomes. MIDAS Disease not only covers the performance of 1.6 million products in 93 countries, but also systematically segments this data by 600 diseases (including 35 tumors).
Building upon the gold-standard data with an added disease dimension
MIDAS Disease offers the added dimension of disease data on-top of the core sales value and volume analysis from MIDAS. This means you can explore your insights like never before and uncover answers to more important business questions, such as:
- What are the sales value and volume of drugs in my disease and country of interest?
- What are the sales value and volume across all diseases for my drug in countries of interest?
- What is my corporation’s share in a disease market?
- What are the treatment options available for my disease of interest?
To delve deeper into MIDAS Disease, we invite you to explore:
A New Dimension: MIDAS Disease Insights Blog Series
To see firsthand how MIDAS Disease can help your business, fill in your details on the form to book a demo.
I’d like to request a demo to see how MIDAS Disease can help me.
